Plants have been traditionally used as sustainable sources of valuable bioproducts, from aromas to medicines. New breeding techniques as CRISPR/Cas editing, in the context of a deeper understanding of plant genomes, open new opportunities for plant biofactories. Which new products can we expect to be produced in plants in the future? How is this opportunity being affected by EU legislation on plant biotechnology?
This workshop will bring together a multidisciplinary group of international scientists working in two related EU projects, Newcotiana and Pharma Factory to discuss their advances and perspectives in the field.
Where: Salón de actos cubo azul CPI-UPV, Valencia
When: March 7th, 2019. 09.00-13.30h
How: This is an open Workshop. If you plan to attend, please register here to facilitate logistics.
09:00 – 09:15 Welcome – JP Beltran (CSIC); P. Vera (IBMCP)
09:15 – 10:00 Short introduction to Pharma Factory, CHIC and Newcotiana projects – Julian Ma (St. Georges´s Hospital, University of London); Dirk Bosh (Wageningen University, The Netherlands); Diego Orzaez (IBMCP-CSIC)
10:00 – 10:45 Beyond plants: Update on CRISPR Gene Editing tools and applications – Lluis Montoliu, CNB, Spain
10:45 – 11:15 Coffee break
11:15 – 11:45 The genome of the model plant biofactory N. benthamiana – Peter Waterhouse, Queensland University, Australia
11:45 – 12:15 Let us not read more in ECJ rulings than they actually say– Piet van der Meer, Gent University, Belgium
12:15 – 13:00 Round table: Genome editing in crops after ECJ ruling – Piet van der Meer, Leire Escajedo (EHU, Spain), Dirk Bosh (WUR, Holanda), Andy Wigdorovitz (INTA-Argentina).